Andelyn Biosciences Opens New 180,000-Square-Foot Manufacturing Headquarters 

Andelyn Biosciences opens a new 180,000-square-foot manufacturing headquarters.

The cell and gene therapies developer and manufacturers’ new headquarters, the Andelyn Corporate Center (ACC), is located in the Innovation District in Columbus, Ohio, and aligns with the company’s milestone celebration of over 20 years of leadership and innovation.

The newly constructed facility includes office, laboratory, and manufacturing spaces.

The facility also includes a warehouse and corporate headquarters space, quality control labs, and 16 cGMP modular manufacturing suites with solution prep, upstream, downstream, and filling capabilities.

The expansion provides space to meet increasing cell and gene therapy needs, and enhances Andelyn Biosciences Concept-to-Commercialization capabilities for biotechnology and pharmaceutical clients.

See Andelyn's new production facility for cell and gene therapy manufacturing in Columbus, Ohio.

Previous
Previous

Biotech, Life Science Building Owners Look to a Post-COVID Future

Next
Next

U.S. BioLife SciSafe Biostorage Facilities Receive CAP Accreditation